The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxy-phenyl)methylene]indolin-2-one ID: ALA5285058
Max Phase: Preclinical
Molecular Formula: C15H9Br2NO3
Molecular Weight: 411.05
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Nc2ccc(Br)cc2/C1=C/c1cc(O)c(O)c(Br)c1
Standard InChI: InChI=1S/C15H9Br2NO3/c16-8-1-2-12-9(6-8)10(15(21)18-12)3-7-4-11(17)14(20)13(19)5-7/h1-6,19-20H,(H,18,21)/b10-3-
Standard InChI Key: GPKLWRHHVIBYEO-KMKOMSMNSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
-0.3924 2.0123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4325 2.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6827 1.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0291 0.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6383 1.2296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0025 2.6287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8241 2.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0747 1.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5076 1.0224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8881 1.4262 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-1.4516 1.0116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0291 -0.1044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7000 -0.5254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7003 -1.3676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4277 -1.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1572 -1.3655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1588 -0.5276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4324 -0.1026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4277 -2.6287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8864 -1.7866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8881 -0.1066 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
1 5 1 0
5 4 1 0
2 6 1 0
7 6 2 0
8 7 1 0
9 8 2 0
3 9 1 0
8 10 1 0
5 11 2 0
4 12 2 0
12 13 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
13 18 1 0
15 19 1 0
16 20 1 0
17 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.05Molecular Weight (Monoisotopic): 408.8949AlogP: 4.12#Rotatable Bonds: 1Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.61CX Basic pKa: ┄CX LogP: 4.20CX LogD: 3.99Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.49Np Likeness Score: 0.07
References 1. Ahamad S, Bhat SA.. (2022) The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease., 65 (24.0): [PMID:36490325 ] [10.1021/acs.jmedchem.2c00799 ]